Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT458
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,271
Award facts
- Contract value 100% obligated
- $19,270.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) valued at $19,270.64 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by October 31, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's procurement of pharmaceuticals to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this prime IDC to supply a broad range of medications and medical supplies to support Defense Health Agency operations and other federal healthcare customers. The contract demonstrates the vendor's established capability to fulfill federal medical procurement requirements through competitive contracting processes and its role as a critical supplier within the military's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FT458?
SPE2DR26FT458 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FT458 worth?
The government has obligated $19,271 on SPE2DR26FT458.
Is contract SPE2DR26FT458 an order under another contract?
Yes. SPE2DR26FT458 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT458 competed?
The extent of competition for SPE2DR26FT458 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award